CI TKR/UKR
K031770 · Brainlab AG · HAW · Aug 12, 2003 · Neurology
Device Facts
| Record ID | K031770 |
| Device Name | CI TKR/UKR |
| Applicant | Brainlab AG |
| Product Code | HAW · Neurology |
| Decision Date | Aug 12, 2003 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 882.4560 |
| Device Class | Class 2 |
Intended Use
Ci TKR/UKR is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive marker sensor system to virtual computer image space on an individual 3D-model of the patient's bone, which is generated through acquiring multiple landmarks on the bone surface. The system is indicated for any medical condition in which the use of stereo tactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT, X-ray, MR based model of the anatomy. The system aids the surgeon to accurately navigate a knee prosthesis to the intraoperatively planned position. Ligament balancing and measurements of bone alignment are provided by Ci TKR/UKR.
Device Story
Intraoperative image-guided localization system for orthopedic surgery. Inputs: anatomical landmarks acquired via freehand probe tracked by passive marker sensor system. Processing: generates virtual 3D-model of patient bone; registers landmarks to navigate femoral/tibial cutting guides and implants to planned positions; performs 3D reconstruction of mechanical axis and alignment. Output: visual navigation guidance for surgeon. Used in OR by surgeons. Benefits: enables minimally invasive surgery; assists in accurate implant positioning; provides ligament balancing and alignment measurements. No preoperative CT required.
Clinical Evidence
Bench testing only. No clinical data provided.
Technological Characteristics
Image-guided stereotaxic instrument. Uses passive marker sensor system for tracking freehand probes. Software-based 3D reconstruction of bone anatomy and mechanical axis. Connectivity: reads implant data from external manufacturers (e.g., DePuy).
Indications for Use
Indicated for patients undergoing orthopedic surgical procedures, including total knee replacement, unicondylar knee replacement, ligament balancing, range of motion analysis, cruciate ligament surgery, and patella tracking, where stereotactic surgery is appropriate and rigid anatomical structures can be referenced.
Regulatory Classification
Identification
A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.
Predicate Devices
- BrainLAB Vector Vision® CT-free knee (K021306)
- BrainLAB Kolibri™ Image Guided Surgery System (K014256)
Related Devices
- K080678 — UNI-KNEE 2.0 · Brainlab AG · Jun 6, 2008
- K021306 — VECTORVISION CT-FREE KNEE · Brainlab AG · Oct 25, 2002
- K060727 — VECTORVISION HIP · Brainlab AG · Aug 21, 2006
- K083483 — BRAINLAB HIP UNLIMITED, CI HIP UNLIMITED · Brainlab AG · Apr 8, 2009
- K072716 — VECTOR VISION HIP · Brainlab AG · Oct 12, 2007
Submission Summary (Full Text)
{0}------------------------------------------------
K03/170
# AUG 1 2 2003
# 510 (k) Summary of Safety and Effectiveness for Ci TKR/UKR (Kolibri Knee)
| Manufacturer: | BrainLAB AG | |
|-----------------------------|-----------------------------------------------------------------------------------------------------------|--|
| Address: | Ammerthalstrasse 8<br>85551 Heimstetten<br>Germany<br>Phone: +49 89 99 15 68 0<br>Fax: +49 89 99 15 68 33 | |
| Contact Person: | Mr. Rainer Birkenbach | |
| Summary Date: | June 2, 2003 | |
| Device Name: | | |
| Trade name: | Ci TKR/UKR | |
| Common/Classification Name: | Ci TKR/UKR (Kolibri Knee), BrainLAB Image Guided Surgery System /<br>Instrument, Stereotaxic | |
### Predicate Devices:
## BrainLAB Vector Vision® CT-free knee (K 021306)
#### BrainLAB Kolibri™ Image Guided Surgery System (K014256)
Device Classification Name: Instrument, Stereotaxic Regulatory Class: Class II
#### Intended Use:
Ci TKR/UKR is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive marker sensor system to virtual computer image space on an individual 3D-model of the patient's bone, which is generated through acquiring multiple landmarks on the bone surface. The system is indicated for any medical condition in which the use of stereo tactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT, X-ray, MR based model of the anatomy. The system aids the surgeon to accurately navigate a knee prosthesis to the intraoperatively planned position. Ligament balancing and measurements of bone alignment are provided by Ci TKR/UKR.
{1}------------------------------------------------
Example orthopedic surgical procedures include but are not limited to:
Knee Procedures: Total Knee Replacement Unicondylar Knee Replacement Ligament Balancing Range of Motion Analysis Cruciate Ligament Surgery Patella Tracking
#### Device Description:
Ci TKR/UKR is intended to enable operational planning and navigation in orthopedic surgery. It links a surgical instrument, tracked by flexible passive markers to virtual computer image space on an individual 3D-model of the patient's bone, which is generated through acquiring multiple landmarks on the bone surface. Ci TKR/UKR uses the registered landmarks to navigate the femoral and tibial cutting guides and the implant to the planned optimally position.
Ci TKR/UKR allows 3-dimensional reconstruction of the mechanical axis and alignment of the implants. Ci TKR/UKR software registers the patient data needed for planning and navigating the surgery intraoperatively. No preoperative CT-scanning is necessary.
Ci TKR/UKR software has been designed to read in implant data from DePuy and offers to individually choose the prosthesis during each surgery.
#### Substantial equivalence:
Ci TKR/UKR has been verified and validated according to BrainLAB's procedures for product design and development. The validation proves the safety and effectiveness of the information provided by BrainLAB in this 510 (k) application was found to be substantially equivalent with predicate devices such as the 510(k)-clearance of VectorVision® CT-free knee (K 021306) and of the Kolibri IGS System (K014256).
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle or bird-like figure with three curved lines representing its body and wings. The bird is positioned within a circular border that contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES (USA)" in capital letters. The text is arranged around the circumference of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 1 2 2003
Mr. Rainer Birkenbach Executive Vice President BrainLAB AG Ammerthalstrasse 8 85551 Heimstetten Germany
Re: K031770
Trade/Device Name: Ci TKR/ÜKR (Kolibri Knee) Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: June 2, 2003 Received: June 9, 2003
Dear Mr. Birkenbach :
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2 - Mr. Rainer Birkenbach
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Wily Witt
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
510(k) Number (if known):
Device Name:
Ci TKR/UKR (Kolibri Knee)
Ko31770
Indications For Use:
Ci TKR/UKR is intended to be an intraoperative image guided localization system to enable minimally invasive surgery. It links a freehand probe, tracked by a passive marker sensor system to virtual computer image space on an individual 3D-model of the patient's bone, which is generated through acquiring multiple landmarks on the bone surface. The system is indicated for any medical condition in which the use of stereo tactic surgery may be appropriate and where a reference to a rigid anatomical structure, such as the skull, a long bone, or vertebra, can be identified relative to a CT, X-ray, MR based model of the anatomy. The system aids the surgeon to accurately navigate a knee prosthesis to the intraoperatively planned position. Ligament balancing and measurements of bone alignment are provided by Ci TKR/UKR.
Example orthopedic surgical procedures include but are not limited to:
Knee Procedures: Total Knee Replacement Unicondylar Knee Replacement Ligament Balancing Range of Motion Analysis Cruciate Ligament Surgery Patella Tracking
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109) OR
Over-The-Counter Use
(Optional Format 1-2-96)
Wla Witt
(Division Sign-Off)
510(k) Number K03177